thymosin beta 4 and bpc-157 / TB-500 Blend | Research Peptide Combination BPC-157 & TB-500 Blend (10mg/20mg)
Description
For patients already engaged in a comprehensive longevity program that includes metabolic monitoring, MOTS-c fits naturally into the toolkit
The peptide has demonstrated efficacy in normalizing pathological blood pressure states, reversing hypertension induced by NOS inhibitors and attenuating hypotension induced by excessive NO substrate administration, indicating adaptive vascular regulation
This makes the risk of side effects very low
BPC-157 (250 to 500 mcg per day) accelerates initial tissue repair while GHK-Cu (1 to 2 mg per day) excels at collagen remodeling and scar reduction
